Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
株式のランク #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
株価
$419.17
時価総額
$333.66B
変化(1日)
0.50%
変化(1年)
14.13%
CH
取引 Roche Holding AG (ROG)

カテゴリー

Roche Holding AG(ROG)の利益
Dec 2025 時点の利益 TTM: $21.39B
Roche Holding AG の最新の財務報告によると、同社の現在の利益は $21.39B です。2024 年には $13.06B の利益を上げ、これは 2023 年の利益 $16.74B と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Roche Holding AG の利益の推移(2000 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
同業他社の利益
企業 利益 利益の差